Absci Corporation (ABSI) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
Absci Corporation presented at the Jefferies Global Healthcare Conference 2026, highlighting its AI-driven drug discovery platform. CEO Sean McClain discussed the company's focus on accelerating drug development timelines and its differentiated pipeline. The presentation included details on two specific programs targeting hair regrowth and endometriosis.
- ▪Absci Corporation is an AI drug creation company.
- ▪The company aims to reduce the time it takes to bring new drugs to the clinic.
- ▪Absci's pipeline includes programs focused on prolactin receptor biology.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4912480-absci-corporation-absi-presents-at-jefferies-global-healthcare-conference-2026-prepared"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
